{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T19:42:51Z","timestamp":1776022971594,"version":"3.50.1"},"reference-count":95,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Biochem &amp;amp; Molecular Tox"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Gall bladder cancer is a formidable malignancy known for its aggressive nature and often late\u2010stage diagnosis. In recent years, oncology has changed basic assumptions towards personalized and targeted therapies. Significant emphasis has been paid to research and clinical contexts about DNA methylation, histone changes, and microRNA alterations as key epigenetic pathways linked to the development of gall bladder cancer. The review delves into the potential of epigenetic markers as diagnostic and prognostic tools and discusses their utility in finding novel therapeutic targets. Targeted therapies have demonstrated effectiveness in addressing various types of cancer, and gall bladder cancer is no exception. The recent advancements in targeted therapies tailored for gall bladder cancer have been elaborated, underscoring the vital role of precision medicine in customizing treatment plans to suit individual patients. The review also examines the challenges and opportunities associated with the development of therapies specifically designed to target epigenetic changes, potentially offering treatment options that are both more efficacious and less toxic.<\/jats:p>","DOI":"10.1002\/jbt.70403","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T07:24:58Z","timestamp":1753255498000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic Regulation and Targeted Therapy in Gall Bladder Cancer"],"prefix":"10.1002","volume":"39","author":[{"given":"Devbrat","family":"Singh","sequence":"first","affiliation":[{"name":"Amity Institute of Biotechnology Amity University Uttar Pradesh Lucknow Campus Lucknow India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1977-7330","authenticated-orcid":false,"given":"Sayali","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Amity Institute of Biotechnology Amity University Uttar Pradesh Lucknow Campus Lucknow India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"e_1_2_19_2_1","unstructured":"Globocan 2022.Data Visualization Tools for Exploring the Global Burden in 2022 https:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/900-world-fact-sheets.pdf."},{"key":"e_1_2_19_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59040660"},{"key":"e_1_2_19_4_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1761440"},{"key":"e_1_2_19_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2018.03.053"},{"key":"e_1_2_19_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2016.04.047"},{"key":"e_1_2_19_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225671"},{"key":"e_1_2_19_8_1","doi-asserted-by":"publisher","DOI":"10.21037\/cco.2019.07.12"},{"key":"e_1_2_19_9_1","volume-title":"InStatPearls [Internet]","author":"Jones M. W.","year":"2022"},{"key":"e_1_2_19_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00398-y"},{"key":"e_1_2_19_11_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i22.3978"},{"key":"e_1_2_19_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2004.03355.x"},{"key":"e_1_2_19_13_1","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.94862"},{"key":"e_1_2_19_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp220"},{"key":"e_1_2_19_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2019.111674"},{"key":"e_1_2_19_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31585"},{"key":"e_1_2_19_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/1868-7083-4-11"},{"key":"e_1_2_19_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12010198"},{"key":"e_1_2_19_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/mc.20457"},{"key":"e_1_2_19_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2020.03.003"},{"key":"e_1_2_19_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105801"},{"key":"e_1_2_19_22_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.223198"},{"key":"e_1_2_19_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7338"},{"key":"e_1_2_19_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154682"},{"key":"e_1_2_19_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002619900169"},{"key":"e_1_2_19_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2013.03.022"},{"key":"e_1_2_19_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2007.11.011"},{"key":"e_1_2_19_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2003.10.003"},{"key":"e_1_2_19_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz402"},{"key":"e_1_2_19_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-007-0673-7"},{"key":"e_1_2_19_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy282"},{"key":"e_1_2_19_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70301-1"},{"key":"e_1_2_19_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-1069-7"},{"key":"e_1_2_19_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.11.018"},{"key":"e_1_2_19_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyy082"},{"key":"e_1_2_19_36_1","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn.2019.04.11"},{"key":"e_1_2_19_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2018.09.002"},{"key":"e_1_2_19_38_1","doi-asserted-by":"publisher","DOI":"10.1159\/000510998"},{"key":"e_1_2_19_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00324-2"},{"key":"e_1_2_19_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7219-7_1"},{"key":"e_1_2_19_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goaa026"},{"key":"e_1_2_19_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2018.11.001"},{"key":"e_1_2_19_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-014-0276-y"},{"key":"e_1_2_19_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77939-6"},{"key":"e_1_2_19_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000682"},{"key":"e_1_2_19_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082051"},{"key":"e_1_2_19_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-018-0064-z"},{"key":"e_1_2_19_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00015"},{"key":"e_1_2_19_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-014-0082-8"},{"key":"e_1_2_19_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.02.004"},{"key":"e_1_2_19_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds008"},{"key":"e_1_2_19_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv035"},{"key":"e_1_2_19_53_1","unstructured":"A. C.Tan D. Y.Oh Y.Chao et al. Efficacy and Safety of Varlitinib a Reversible Pan\u2010HER Tyrosine Kinase Inhibitor in Combination With Platinum\u2010Based Regimens in Biliary Tract Cancers: A Pooled Analysis From Three Phase I Studies."},{"key":"e_1_2_19_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature25475"},{"key":"e_1_2_19_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-0927-7"},{"key":"e_1_2_19_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5223-7"},{"key":"e_1_2_19_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.3579"},{"key":"e_1_2_19_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.801"},{"key":"e_1_2_19_59_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0253"},{"key":"e_1_2_19_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.07.143"},{"key":"e_1_2_19_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70212-8"},{"key":"e_1_2_19_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt416"},{"key":"e_1_2_19_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07365-4"},{"key":"e_1_2_19_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31872"},{"key":"e_1_2_19_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32964"},{"key":"e_1_2_19_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00139-4"},{"key":"e_1_2_19_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.09.013"},{"key":"e_1_2_19_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605458"},{"key":"e_1_2_19_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.9473"},{"key":"e_1_2_19_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.01.026"},{"key":"e_1_2_19_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-018-0600-2"},{"key":"e_1_2_19_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0523-5"},{"key":"e_1_2_19_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2021.1928636"},{"key":"e_1_2_19_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(16)30326-4"},{"key":"e_1_2_19_75_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9205851"},{"key":"e_1_2_19_76_1","unstructured":"F.Meric\u2010Bernstam D. L.Hanna A. B.El\u2010Khoueiry et al. Zanidatamab (ZW25) in HER2\u2010Positive Biliary Tract Cancers (BTCs): Results From a Phase I Study."},{"key":"e_1_2_19_77_1","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2020.03240"},{"key":"e_1_2_19_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30321-1"},{"key":"e_1_2_19_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-014-0096-3"},{"key":"e_1_2_19_80_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu175"},{"key":"e_1_2_19_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00336-3"},{"key":"e_1_2_19_82_1","unstructured":"M. M.Javle J. D.Hainsworth C.Swanton et al. Pertuzumab+ Trastuzumab for HER2\u2010Positive Metastatic Biliary Cancer: Preliminary Data From MyPathway."},{"key":"e_1_2_19_83_1","unstructured":"Y. J.Bang M.Ueno D.Malka et al. Pembrolizumab (Pembro) for Advanced Biliary Adenocarcinoma: Results From the KEYNOTE\u2010028 (KN028) and KEYNOTE\u2010158 (KN158) Basket Studies."},{"key":"e_1_2_19_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30086-X"},{"key":"e_1_2_19_85_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0044"},{"key":"e_1_2_19_86_1","unstructured":"T.Ioka M.Ueno D. Y.Oh et al. Evaluation of safety and tolerability of durvalumab (D) with or without tremelimumab (T) in patients (pts) with biliary tract cancer (BTC)."},{"key":"e_1_2_19_87_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098441"},{"key":"e_1_2_19_88_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000564"},{"key":"e_1_2_19_89_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.0930"},{"key":"e_1_2_19_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature02797"},{"key":"e_1_2_19_91_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24309"},{"key":"e_1_2_19_92_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7618"},{"key":"e_1_2_19_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2014.04.053"},{"key":"e_1_2_19_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44767-3"},{"key":"e_1_2_19_95_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322658"},{"key":"e_1_2_19_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36399-y"}],"container-title":["Journal of Biochemical and Molecular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbt.70403","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbt.70403","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbt.70403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T18:56:25Z","timestamp":1776020185000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jbt.70403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":95,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1002\/jbt.70403"],"URL":"https:\/\/doi.org\/10.1002\/jbt.70403","archive":["Portico"],"relation":{},"ISSN":["1095-6670","1099-0461"],"issn-type":[{"value":"1095-6670","type":"print"},{"value":"1099-0461","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"2025-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70403"}}